Skip to main content
Livermore
Livermore
ZHEN

Barclays PLC

SEC CIK
0000312069
Latest filing
Aug 14, 2026

ELV holding history

Elevance Health, Inc. in every 13F filed by Barclays PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELV overviewAll 13F holders of ELVFull Q2 2026 holdings

Shares (Q2 2026)
423,616
Value
$163.8M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ELV by Barclays PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026423,616$163.8M0.1%−415,284−49.5%ReducedHolders
Q1 2026838,900$245.6M0.1%+460,014+121.4%AddedHolders
Q4 2025378,886$132.8M0.1%−175,435−31.6%ReducedHolders
Q3 2025554,321$179.1M0.1%−39,953−6.7%ReducedHolders
Q2 2025594,274$231.1M0.1%+90,842+18.0%AddedHolders
Q1 2025503,432$219.0M0.1%+54,352+12.1%AddedHolders
Q4 2024449,080$165.7M0.1%−172,004−27.7%ReducedHolders
Q3 2024621,084$323.0M0.1%−368,538−37.2%ReducedHolders
Q2 2024989,622$536.2M0.2%−35,466−3.5%ReducedHolders
Q1 20241,025,088$531.5M0.2%−209,835−17.0%ReducedHolders
Q4 20231,234,923$582.3M0.3%+142,245+13.0%AddedHolders
Q3 20231,092,678$475.8M0.3%−170,723−13.5%ReducedHolders
Q2 20231,263,401$561.3M0.4%+437,225+52.9%AddedHolders
Q1 2023826,176$379.9M0.4%+46,111+5.9%AddedHolders
Q4 2022780,065$400.1M0.3%+327,413+72.3%AddedHolders
Q3 2022452,652$205.6M0.2%+104,400+30.0%AddedHolders
Q2 2022348,252$168.1M0.2%−134,530−27.9%ReducedHolders
Q1 2022482,782$237.2M0.2%−169,204−26.0%ReducedHolders
Q4 2021651,986$302.2M0.2%+21,222+3.4%AddedHolders
Q3 2021630,764$235.1M0.2%+115,734+22.5%AddedHolders
Q2 2021515,030$196.6M0.2%+59,614+13.1%AddedHolders
Q1 2021455,416$163.5M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.